Choong Ang Vaccine Laboratory Co. Ltd (072020) — Cash Flow-to-Debt Ratio
Choong Ang Vaccine Laboratory Co. Ltd (072020) has a Cash Flow-to-Debt Ratio of 0.13x as of March 2026, meaning its operating cash flow of ₩2.30 Billion could theoretically repay 0% of its total liabilities (₩17.61 Billion) in one year. See Choong Ang Vaccine Laboratory Co. Ltd (072020) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Choong Ang Vaccine Laboratory Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Choong Ang Vaccine Laboratory Co. Ltd across 12 annual periods. For the full cash flow conversion analysis, see Choong Ang Vaccine Laboratory Co. Ltd (072020) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for Choong Ang Vaccine Laboratory Co. Ltd. Check how high is Choong Ang Vaccine Laboratory Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | ₩7.87 Billion | ₩17.45 Billion | ▼ -34.7% |
| 2024 | 0.69x | ₩13.40 Billion | ₩19.41 Billion | ▲ +7.5% |
| 2023 | 0.64x | ₩12.71 Billion | ₩19.79 Billion | ▲ +77.2% |
| 2022 | 0.36x | ₩7.09 Billion | ₩19.55 Billion | ▼ -37.2% |
| 2021 | 0.58x | ₩11.53 Billion | ₩19.98 Billion | ▲ +20.9% |
| 2020 | 0.48x | ₩8.32 Billion | ₩17.43 Billion | ▼ -41.4% |
| 2019 | 0.81x | ₩8.30 Billion | ₩10.20 Billion | ▲ +67.3% |
| 2018 | 0.49x | ₩5.71 Billion | ₩11.74 Billion | ▲ +9.0% |
| 2017 | 0.45x | ₩7.56 Billion | ₩16.95 Billion | ▼ -23.7% |
| 2016 | 0.59x | ₩7.71 Billion | ₩13.18 Billion | ▼ -57.4% |
| 2015 | 1.37x | ₩9.93 Billion | ₩7.22 Billion | ▲ +77.5% |
| 2014 | 0.77x | ₩6.67 Billion | ₩8.61 Billion | — |